Cargando…

Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer-related death worldwide. Due to the lack of efficient tools for early detection, asymptomatic HCC patients are diagnosed at an advanced stage, leading to a poor prognosis. To improve survival, serum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yang, Li, Guangbing, Lu, Ziwen, Liu, Yong, Kong, Junjie, Liu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660097/ https://www.ncbi.nlm.nih.gov/pubmed/34900676 http://dx.doi.org/10.3389/fonc.2021.726213

Ejemplares similares

Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma
por: Wang, Xiumei, et al.
Publicado: (2017)

Second Primary Malignancies in Patients With Hepatocellular Carcinoma: A Population-Based Analysis
por: Kong, Junjie, et al.
Publicado: (2021)

Clinical Utility of Protein Induced by Vitamin K Absence-II in Patients with Hepatocellular Carcinoma
por: Bhatti, Abu Bakar H, et al.
Publicado: (2021)

Protein Induced by Vitamin K Absence II: A Potential Biomarker to Differentiate Pancreatic Ductal Adenocarcinoma from Pancreatic Benign Lesions and Predict Vascular Invasion
por: Yang, Yang, et al.
Publicado: (2023)

Vitamin K2 Inhibits Hepatocellular Carcinoma Cell Proliferation by Binding to 17β-Hydroxysteroid Dehydrogenase 4
por: Lu, Xin, et al.
Publicado: (2021)

Cutoff values of protein induced by vitamin K absence or antagonist II for diagnosing hepatocellular carcinoma
por: Jang, Tyng-Yuan, et al.
Publicado: (2022)

Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population
por: Yu, Rentao, et al.
Publicado: (2015)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

Evaluation of Prothrombin Response to Vitamin K as Liver Function Test
por: Wahi, P. N.
Publicado: (1947)

A commentary on ‘Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: a retrospective cohort study’ (Int J Surg 2022;105:106843)
por: Zhou, Zheyu, et al.
Publicado: (2023)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023)

Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma
por: Kong, Junjie, et al.
Publicado: (2022)

Role of Forkhead Box O Proteins in Hepatocellular Carcinoma Biology and Progression (Review)
por: Yang, Shaojie, et al.
Publicado: (2021)

Vitamin D: Possible Therapeutic Roles in Hepatocellular Carcinoma
por: Adelani, Isaacson B., et al.
Publicado: (2021)

Hepatocellular Carcinoma Differentiation: Research Progress in Mechanism and Treatment
por: Song, Jianning, et al.
Publicado: (2022)

Research Progress of DUB Enzyme in Hepatocellular Carcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Sema3d Restrained Hepatocellular Carcinoma Progression Through Inactivating Pi3k/Akt Signaling via Interaction With FLNA
por: Li, Yiming, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
por: Liu, Hao-Tian, et al.
Publicado: (2021)

Inflammatory Hepatocellular Adenoma with Elevated Serum Protein Induced by Vitamin K Absence/Antagonist-II in Adult Males
por: Koya, Yudai, et al.
Publicado: (2019)

Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
por: Gong, Yihang, et al.
Publicado: (2021)

Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
por: Wu, Shilun, et al.
Publicado: (2022)

Protein Induced by Vitamin K Absence or Antagonist-II Versus Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
por: Kobeissy, Abdallah, et al.
Publicado: (2023)

The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study
por: Dahlberg, Sofia, et al.
Publicado: (2021)

Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis
por: Zhu, Rong, et al.
Publicado: (2014)

The progress of prothrombin time measurement
por: Horsti, Juha
Publicado: (2009)

Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices
por: Tao, Ziwen, et al.
Publicado: (2021)

A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma
por: De, Ji, et al.
Publicado: (2016)

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression
por: Zhang, Ying, et al.
Publicado: (2022)

Vitamin D Status and Survival in Stage II-III Colorectal Cancer
por: Bao, Yichao, et al.
Publicado: (2020)

Safety and efficacy of a strategy of vitamin K antagonist reversal with prothrombin complex concentrates compared to vitamin K in patients with hip fracture
por: Jay-Caillierez, Lucille, et al.
Publicado: (2021)

Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma
por: Xu, Yiwei, et al.
Publicado: (2023)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

FNDC5 Causes Resistance to Sorafenib by Activating the PI3K/Akt/Nrf2 Pathway in Hepatocellular Carcinoma Cells
por: Liu, Huayuan, et al.
Publicado: (2022)

Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma
por: You, Junqi, et al.
Publicado: (2023)

Hepatocellular Senescence: Immunosurveillance and Future Senescence-Induced Therapy in Hepatocellular Carcinoma
por: Liu, Peng, et al.
Publicado: (2020)

BLEEDING TENDENCY AND PROTHROMBIN DEFICIENCY IN BILIARY FISTULA DOGS: EFFECT OF FEEDING BILE AND VITAMIN K
por: Smith, H. P., et al.
Publicado: (1938)

Reversal of Vitamin K Antagonist Therapy by Prothrombin Complex Concentrate before Thrombolysis for Acute Stroke
por: Chausson, Nicolas, et al.
Publicado: (2013)

Efficacy and safety of activated prothrombin complex concentrate for the reversal of vitamin K antagonist major bleeding
por: Sheikh-Taha, Marwan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qmud51v7h0a27nv7o2o2q7c923